Mechanism of spontaneous and DSB-induced repair

$592,173R37FY2013GMNIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications, trials & patents

Paper 28794266 Paper 27558135 Paper 26974669 Paper 25731763 Paper 25381364 Paper 24376557 Paper 24097900 Paper 24097410 Paper 23790361 Paper 23589890 Paper 23357952 Paper 23335335 Paper 23028367 Paper 22522342 Paper 22493290 Paper 22157747 Paper 22033189 Paper 21459050 Paper 21441915 Paper 21372173 Paper 21368826 Paper 21173034 Paper 21047263 Paper 20584323 Paper 20566477 Paper 20178629 Paper 20014044 Paper 19892607 Paper 19812039 Paper 19729509 Paper 19506039 Paper 19490890 Paper 19473884 Paper 19346480 Paper 19262568 Paper 19214189 Paper 19129197 Paper 19022748 Paper 18832360 Paper 18406328 Paper 18285819 Paper 18272435 Paper 18085829 Paper 18070937 Paper 17888746 Paper 17643116 Paper 17591698 Paper 17418443 Paper 17096599 Paper 17083134 Paper 16987715 Paper 16816432 Paper 16707661 Paper 15989975 Paper 15889139 Paper 15654096 Paper 15222768 Paper 12963848 Paper 12760048 Paper 12399378 Paper 12073318 Paper 12073317 Paper 12072453 Paper 11904430 Paper 11459964 Paper 11432841 Paper 11074005 Paper 10717390 Paper 10640269 Paper 10594025 Patent 7125658

Abstract

Our goal is to understand the mechanisms underlying the recognition and repair of DMA damage. We use yeast as an experimental organism to continue our studies on three different aspects of this essential biological process. The specific aims of this proposal are focused on the following three subjects: (1) The Rad52 DNA repair protein: We will continue our molecular genetic characterization of the Rad52 DNA repair pathway using Rad52-fluorescent protein fusions. We will follow up on leads from our genomic screen of the yeast gene disruption library to study the role of novel helicases and other DNA metabolism genes in Rad52 focus formation. We will continue to explore Rad52 function with respect to post-translational modifications such as SUMO and phosphorylation, (2) Sml1, a negative regulator of RNR: We will continue to investigate the regulatory circuitry of the Rnr Inhibitor, SmII. We will determine which pathways and what modifications regulate Smil degradation during S phase and after DNA damage. We have gained a wealth of information from our screen for genes that affect Sml1 protein levels after DNA damage. We will examine how spindle checkpoint proteins and kinetochore proteins are involved in this regulation. (3) The Top3/Sgs1 DNA topoisomerase/hellcase complex: We will continue to explore the genetic and biochemical interactions between TopS, Sgsl and Rmil. We will study a separation of function allele of Sgsl. We will further characterize the role of the Shu suppressor complex (Shu1/Shu2/Psy3/Csm2) in en-or-free repair. We will continue screening the yeast gene disruption library for additional genes that interact with TopS, Sgsl and Rmi1 using a SPA - specific ploldy ablation, our newly developed method. It is these combined genetic and cell biological approaches to the many issues related to the recognition and repair of DNA damage In yeast that will continue to yield insights into this important biological process.

View original record on NIH RePORTER →